Conference Coverage: ESMO 2023 – Focus on Lung Cancer

Expert perspectives and strategic insights on the latest therapeutic developments and translational research in lung cancer treatment

October 23, 2023
Corey Langer MD Scientific Leader Faculty Chair Aptitude Health

Faculty Chair

Corey J. Langer, MD, FACP

University of Pennsylvania, Philadelphia, USA


Federico Cappuzzo, MD, PhD
AUSL della Romagna-Ravenna, Italy

Egbert Smit, MD, PhD
The Netherlands Cancer Institute, Amsterdam, the Netherlands

Christian Rolfo, MD, PhD
Icahn School of Medicine at Mount Sinai, New York, NY, USA

Sandip Patel, MD
UC San Diego Health, CA, USA

Marina Chiara Garassino, MD
University of Chicago, IL, USA

Sample Report

Start discovering the insights

View Report


  • Immunotherapy in Resectable NSCLC
  • Immunotherapy in Stage III/IV NSCLC
  • Second-Line Therapy and Beyond
  • Oncogene-Driven NSCLC: EGFR
  • Oncogene-Driven NSCLC: Other Mutations
  • Oncogene-Driven NSCLC: Fusions
  • SCLC and New Agents/Targets
  • Open Discussion: Major Breakthroughs Over the Coming Years in Lung Cancer

Purchase Report

Thank you for your interest in our insights.

Complete the form below to receive additional information.